Campaign for Vermont
  • About
    About Vision for Vermont Who We Are Board of Directors Advisory Council Our Story Frequent Questions
  • Issues
    Issues Economic Prosperity Financial Sustainability World Class Education A Robust Social Safety Net Government Accountability
  • Take Action
    Take Action Contact Your Legislators Join Us Volunteer
  • News
  • Contact
  • Sign in
  • Contribute Now
  • About
    About Vision for Vermont Who We Are Board of Directors Advisory Council Our Story Frequent Questions
  • Issues
    Issues Economic Prosperity Financial Sustainability World Class Education A Robust Social Safety Net Government Accountability
  • Take Action
    Take Action Contact Your Legislators Join Us Volunteer
  • News
  • Contact
  • More
    About Issues Take Action News Contact
    About Vision for Vermont Who We Are Board of Directors Advisory Council Our Story Frequent Questions
    Issues Economic Prosperity Financial Sustainability World Class Education A Robust Social Safety Net Government Accountability
    Take Action Contact Your Legislators Join Us Volunteer
  • Sign in
Contribute Now

Pages tagged “S.98 2024”

  • GMCB Oversight of Drug Prices (S.98) - May 1, 2024

    On Tuesday, Nolan Langweil (Principal Fiscal Analyst, Joint Fiscal Office)  reviewed S.98 with the House Appropriations Committee. The bill relates to Green Mountain Care Board (GMCB) authority over prescription drug costs. The House Health Care Committee had made amendments concerning the GMCB Nominating Committee, and then passed the bill on to this Committee.

    Ben Kinsley

    Written by Ben Kinsley
    May 01, 2024

  • GMCB Oversight of Drug Prices (S.98) - March 15, 2024

    Jennifer Carbee (Director, Office of Legislative Counsel) reviewed amendments on S.98 on Friday. It is an act relating to Green Mountain Care Board (GMCB) authority over prescription drug costs. It specifies that the GMCB, in consultation with its own technical advisory groups and other state agencies, shall explore and create a framework and methodology for implementing a program to oversee the cost of prescription drugs for Vermont consumers and Vermont’s health care system. The Board shall consider options for and likely impacts of regulating the cost of prescription drugs that includes prescription drug affordability.

    Gail Graham

    Written by Gail Graham
    March 17, 2024

  • GMCB Oversight of Drug Prices (S.98) - Feb 8, 2024

    Charles Becker (Staff Attorney, Office of Health Care Advocate (HCA)) testified before the Senate Health & Welfare Committee on Thursday morning about S.98, an act relating to GMCB authority over prescription drug costs. He specifically addressed Copay Accumulator Adjustment Programs, considering them to be a problem in need of a solution. He believes at least part of the problem is that we have a system based on hidden discounts and rebates that incentivizes high drug list prices.

    Gail Graham

    Written by Gail Graham
    February 08, 2024

  • GMCB Oversight of Drug Prices (S.98) - Feb 2, 2024

    Susan Barrett (Executive Director, Green Mountain Care Board (GMCB)) and Julia Boles (Health Policy Advisor, GMCB) opened the Friday session with Senate Health & Welfare Committee discussing the GMCB. Their mission is to drive system-wide improvements in access, affordability and quality of health care to improve the health of Vermonters. They regulate major areas of Vermont’s health care system in service of the public interest. They also serve as an unbiased source of information and analysis on health system performance. Thirdly, they monitor and evaluate health care payment and delivery system reform to provide public care payment delivery system reform to provide public transparency. 

    Gail Graham

    Written by Gail Graham
    February 02, 2024

© Campaign for Vermont Prosperity Inc. | PO Box 1432, Montpelier, VT 05601-1432 | ‪(802) 828-7098‬

Listed on Vermont.com

Created with NationBuilder